Metformin-capped silver nanoparticles

Intervention1 paper4 findings

  • Animals1

Outcomes

4

Pyroptosis

downin human cells1Very low certainty

1 study
  1. Metformin-capped silver nanoparticles inhibit pyroptosis in human cells.

    Cellsin KGN cells treated with macrophage conditioned medium

    Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026

Pyroptosis →

NLRP3 inflammasome

downin rats1Very low certainty

1 study
  1. Metformin-capped silver nanoparticles inhibit NLRP3 inflammasome in rats.

    Animalsin POI rats

    Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026

NLRP3 inflammasome →

Fertility

upin rats1Very low certainty

1 study
  1. Metformin-capped silver nanoparticles improve fertility in rats.

    Animalsin POI rats

    Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026

Premature ovarian insufficiency

downin rats1Very low certainty

1 study
  1. Metformin-capped silver nanoparticles decrease premature ovarian insufficiency in rats.

    Animalsin POI rats

    Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026

Premature ovarian insufficiency →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01